A detailed history of Crawford Investment Counsel Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 804,648 shares of MRK stock, worth $91.4 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares
804,648
Previous 811,729 0.87%
Holding current value
$91.4 Million
Previous $107 Million 6.99%
% of portfolio
1.91%
Previous 2.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $876,627 - $941,489
-7,081 Reduced 0.87%
804,648 $99.6 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $1.37 Million - $1.6 Million
-12,115 Reduced 1.47%
811,729 $107 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $2.74 Million - $2.98 Million
-27,345 Reduced 3.21%
823,844 $89.8 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $1.02 Million - $1.13 Million
-9,914 Reduced 1.15%
851,189 $87.6 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $1.08 Million - $1.17 Million
-9,916 Reduced 1.14%
861,103 $99.4 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $18.7 Million - $20.9 Million
-181,987 Reduced 17.28%
871,019 $92.7 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $12.3 Million - $15.7 Million
-140,303 Reduced 11.76%
1,053,006 $117 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $59,340 - $66,661
702 Added 0.06%
1,193,309 $103 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $239,115 - $271,048
2,864 Added 0.24%
1,192,607 $109 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $9.22 Million - $10.3 Million
-125,430 Reduced 9.54%
1,189,743 $97.6 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $1.79 Million - $2.24 Million
-24,792 Reduced 1.85%
1,315,173 $101 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $2.23 Million - $2.45 Million
31,136 Added 2.38%
1,339,965 $101 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $18.7 Million - $20.7 Million
266,133 Added 25.52%
1,308,829 $102 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $4.11 Million - $4.84 Million
59,723 Added 6.08%
1,042,696 $80.4 Million
Q4 2020

Feb 01, 2021

BUY
$71.77 - $79.65 $711,168 - $789,251
9,909 Added 1.02%
982,973 $80.4 Million
Q3 2020

Oct 29, 2020

BUY
$73.18 - $82.95 $685,696 - $777,241
9,370 Added 0.97%
973,064 $80.7 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $477,799 - $543,682
6,785 Added 0.71%
963,694 $74.5 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $2.57 Million - $3.56 Million
-40,559 Reduced 4.07%
956,909 $73.6 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $76,649 - $86,489
-988 Reduced 0.1%
997,468 $90.7 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $11.2 Million - $12.2 Million
-147,262 Reduced 12.85%
998,456 $84.1 Million
Q2 2019

Aug 12, 2019

SELL
$69.84 - $81.59 $166,428 - $194,428
-2,383 Reduced 0.21%
1,145,718 $96.1 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $8.37 Million - $9.54 Million
-120,254 Reduced 9.48%
1,148,101 $95.5 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $8.08 Million - $9.37 Million
-123,798 Reduced 8.89%
1,268,355 $96.9 Million
Q3 2018

Nov 09, 2018

SELL
$57.69 - $67.84 $1.94 Million - $2.28 Million
-33,580 Reduced 2.36%
1,392,153 $98.8 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $860,602 - $1.01 Million
-16,931 Reduced 1.17%
1,425,733 $86.5 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $3.33 Million - $3.87 Million
65,270 Added 4.74%
1,442,664 $78.6 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $1.41 Million - $1.69 Million
27,396 Added 2.03%
1,377,394 $77.5 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $79.2 Million - $85.2 Million
1,349,998
1,349,998 $86.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Crawford Investment Counsel Inc Portfolio

Follow Crawford Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Investment Counsel Inc with notifications on news.